Skip to main content
  1. Courses
  2. Update on Canine Leptospiro...
  3. Update on Canine Leptospiro...

Update on Canine Leptospirosis: Converging on Consensus

Description

Sponsored by Boehringer Ingelheim

Join us for an engaging live 1- hour webinar on leptospirosis, a zoonotic disease caused by the bacterial spirochete Leptospira. Despite the availability of vaccines, outbreaks continue to plague unvaccinated dog populations in the United States. This comprehensive talk is designed for veterinary professionals and will cover crucial aspects of the disease.

We will delve into the importance of distinguishing between reservoir hosts and incidental hosts, explore how dogs can become infected, and identify the clinical signs that should raise suspicion of leptospirosis. Learn about the latest diagnostic tests, optimal treatment strategies, and preventive measures to manage and control this disease effectively.

We will also discuss the significant updates from the 2023 ACVIM consensus statement on leptospirosis, including vaccination guidelines that influence the frequency of wellness visits for all dogs. Additionally, recommendations will be provided to minimize the risk of zoonotic transmission to owners, veterinary technicians, and veterinarians.

Don't miss this opportunity to enhance your knowledge and improve your practice's approach to leptospirosis.

©2024 Boehringer lngelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-PET-0709-2024

Contributors

  • Jane E. Sykes BVSc(Hons) PhD MPH MBA FNAP Diplomate ACVIM (SAIM)

    Dr. Jane Sykes is a Professor at the University of California-DavisSchool of Veterinary Medicine with a special interest in small animal infectious diseases. She obtained her DVM degree and a PhD in veterinary microbiology at the University of Melbourne in Australia, and completed a residency in small animal internal medicine at the University of Minnesota and is a board certified small animal internal medicine specialist.She joined the faculty at UC Davis in 2002, and obtained an MBA from the University of Georgia(2020) and an MPH from Kansas State University (2023) with an emphasis on infectious diseases and zoonoses. She founded the International Society for Companion Animal Infectious Diseases (ISCAID) in 2006, has coauthored over 130peer-reviewed publications, and is the editor of the textbooksCanine and Feline Infectious Diseases and Greene’s Infectious Diseases of the Dog and Cat (5th ed). Her research interests are focused on infectious diseases of dogs and cats with public health significance.

  • Judy Rose Lanier, CVPM, CVA, DES

    Moderator
    AAHA Learning Programs Manager

    From an early age, Judy Rose was drawn to veterinary medicine through her experiences on a farm in Texas. She pursued veterinary technology at Sul Ross State University in Alpine, Texas, and has since built a career spanning over 25 years in the field. Judy holds certifications as both a Veterinary Assistant and a Veterinary Practice Manager, providing her with a comprehensive view of both clinical and administrative aspects of veterinary practice.

    Previously, Judy served as the Director of Credentialing for the Texas Veterinary Medical Association (TVMA), where she was instrumental in developing continuing education programs for paraprofessionals throughout Texas. Currently, she is an active participant in the veterinary community, engaging with the Veterinary Hospital Managers Association (VHMA), Pride Veterinary Medical Community (Pride VMC), and serving on the American Animal Hospital Association's Diversity, Equity, Inclusion, and Belonging (DEIB) Committee. Judy and her husband now reside in a small mountain town in Colorado, where they live with their beloved pets, Rootbeer Float, Lotus Flower, and Pepsi Cola.

  • Boehringer Ingelheim

    Sponsorship Provider
    ‘Transforming lives’ refers to the broad impact our work has on health, in the healthcare sector and beyond it.

    We care for animals

    The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. By using the synergies between our Animal Health and Human Health businesses and by delivering value through innovation, we enhance the health and well-being of both.

    Who we are

    As a global leader in the animal health industry our more than 9,500 employees serve more than 150 markets worldwide. We are one of the largest providers of vaccines, parasiticides and therapeutics, complemented by diagnostics and monitoring platforms. With a strong presence in the companion animal and livestock segments, we support veterinarians, farmers as well as pet and horse owners. As part of family-owned Boehringer Ingelheim, we are rooted in our family values and take a long-term perspective. As animal enthusiasts, we come to work every day to help improve the lives of animals – be they at home, on the farm or sometimes in the wildlife.

    About Us

    At Boehringer Ingelheim we are driven by the desire to serve humankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our FOCUS articulates who we are and what we strive for, why we exist, how we work and what we want to achieve.

    Learn More about Boehringer Ingelheim..

    ©2024 Boehringer lngelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-PET-0709-2024

October 1, 2024
Tue 12:00 PM MDT

Duration 1H 0M

Already Registered?
AAHA Learning Team
learning@aaha.org